For patients with secondary acute myeloid leukemia (sAML), novel treatment delivery technologies offer the potential to safely administer chemotherapy agents and achieve durable responses in this higher-risk population. As real-world evidence emerges for the treatment of sAML, it is critical that providers are up to date with these updates to make individualized, guideline-aligned treatment decisions. Are you up for the challenge? Test your knowledge on the latest clinical data and different treatment options for sAML with this bite-sized booster quiz.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/latest-evidence-treating-secondary-aml
- Start Date: 2024-05-10 05:00:00
- End Date: 2024-05-10 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Jazz Pharmaceuticals, Inc. - Amount: 33166.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Medical Oncology
Subscribe
Login
0 Comments
Oldest